Cargando…
HCK can serve as novel prognostic biomarker and therapeutic target for Breast Cancer patients
The role of HCK expression in the prognosis of breast cancer patients is unclear. Thus, this study aimed to explore the clinical implications of HCK expression in breast cancer. We assessed HCK expression and genetic variations in breast cancer using Oncomine, GEPIA, UALCAN, and cBioPortal databases...
Autores principales: | Zhu, Xudong, Zhang, Yixiao, Bai, Yang, Gu, Xi, Chen, Guanglei, Sun, Lisha, Wang, Yulun, Qiao, Xinbo, Ma, Qingtian, Zhu, Tong, Bu, Jiawen, Xue, Jinqi, Liu, Caigang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7645343/ https://www.ncbi.nlm.nih.gov/pubmed/33162805 http://dx.doi.org/10.7150/ijms.43161 |
Ejemplares similares
-
CEMIP as a potential biomarker and therapeutic target for breast cancer patients
por: Xue, Jinqi, et al.
Publicado: (2022) -
FSIP2 can serve as a predictive biomarker for Clear Cell Renal Cell Carcinoma prognosis
por: Zhang, Yixiao, et al.
Publicado: (2020) -
KK-LC-1 as a therapeutic target to eliminate ALDH(+) stem cells in triple negative breast cancer
por: Bu, Jiawen, et al.
Publicado: (2023) -
KCNJ15 deficiency promotes drug resistance via affecting the function of lysosomes
por: Qiao, Xinbo, et al.
Publicado: (2023) -
LIPH promotes metastasis by enriching stem‐like cells in triple‐negative breast cancer
por: Zhang, Yixiao, et al.
Publicado: (2020)